WE ARE JAFRAL
JAFRAL IS THE LEADING CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION
JAFRAL is a leading Contract Development and Manufacturing Organization (CDMO)specializing in the production of advanced biologics. With over a decade of experience, JAFRAL provides end-to-end manufacturing services for a wide range of biologics, including plasmid DNA (pDNA), messenger RNA (mRNA), recombinant proteins (rProteins), outer membrane vesicles (OMVs), live biotherapeutic products (LBPs), and bacteriophages.
While JAFRAL is globally recognized for its expertise in phage production, supporting applications across human therapeutics, gene and cell therapy, veterinary medicine, agriculture, dermatology and nutritional supplements, the company has significantly expanded its platform to support the growing demand for biologic-based therapies.
Operating from state-of-the-art GMP-compliant facilities, JAFRAL ensures the highest standards of quality, safety, and regulatory compliance. In addition to upstream and downstream processing, the company offers comprehensive Fill & Finish services, delivering flexible, customized solutions tailored to each client’s therapeutic needs.
Dedicated to innovation, precision and reliability, JAFRAL is your trusted partner in accelerating the development and production of next-generation biologics.
Founder’s Said
Our mission is to advance global health by manufacturing high-quality biologics for next-generation therapies. We specialize in bacteriophages for phage therapies, providing innovative solutions to combat antimicrobial resistance (AMR) and delivering premium biomolecules to empower cutting-edge cell and gene therapies.
Combining scientific expertise with efficient, GMP-compliant manufacturing and reliable fill & finish capabilities, we ensure our products are consistently delivered on time and to the highest standards. Our commitment to excellence drives the development of cost-effective, scalable processes that meet and exceed expectations.
Simply put, our goal is to make a real and lasting impact on patient care worldwide—by producing biologics that improve lives and contribute to a healthier future for all.
Your personal data will be processed by JAFRAL d.o.o. for the purpose of sending newsletters. You can unsubscribe from receiving newsletters at any time by clicking the link provided in the received message. For more information, please refer to our Privacy Policy.
